Medical device company Globus Medical (NYSE:GMED) in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On ...

Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst ...

In this article, we are going to take a look at where Globus Medical, Inc. (NYSE:GMED) stands against the other high growth healthcare stocks. During lean economic times, investing in healthcare ...

but between legacy GMED, and NuVasive looking ahead and I had a follow-up. And with no further questions that concludes the Globus Medical Earnings Call. Thank you for participating. You may now ...

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, ...

GLOBUS MEDICAL ($GMED) posted quarterly earnings results on Thursday, February 20th. The company reported earnings of $0.84 per share, beating estimates of $0.76 by ...

Globus Medical (NYSE:GMED) just reported results for the second quarter of 2024. Globus Medical reported earnings per share of 75 cents. This was above the analyst estimate for EPS of 68 cents.

Globus Medical, Inc. GMED is well-poised for growth in the coming quarters, backed by the recent NuVasive merger, which brings a comprehensive offering of musculoskeletal procedural solutions and ...

Welcome to Globus Medical's second quarter 2023 earnings call. [Operator instructions] I will now turn the call over to Brian Kearns, senior vice president of business development and investor ...